Posters

Disease characteristics, clinical and patient reported outcomes in psoriasis patients treated with secukinumab

Disease characteristics, clinical and patient reported outcomes in psoriasis patients treated with secukinumab in a US real-world setting: Effectiveness Results from the Corrona Psoriasis Registry

Summary:
•Psoriasis is a chronic, immune-mediated disease whose key clinical symptoms include skin itching, pain, and scaling. Many psoriasis patients have reported decreases in their quality of life (QoL) and work productivity •Secukinumab is a fully human monoclonal antibody that selectively neutralizes IL-17A, clinical trials have shown significant efficacy in the treatment of moderate to severe -psoriasis (PsO) and psoriatic arthritis (PsA) •Little is known on secukinumab’s effectiveness on psoriasis in a real world setting
Authors:
Bruce Strober, Vivian Herrera, Peter Hur, Chitra Karki, Marc Mason, Kimberly Siu, Adriana Guana, Jeffrey D Greenberg, Mark Lebwohl
Tags:
PDF icon Download (559.36 KB)